Bando H - Search Results

1

Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.

Masuda N, Bando H, Yamanaka T, Kadoya T, Takahashi M, Nagai SE, Ohtani S, Aruga T, Suzuki E, Kikawa Y, Yasojima H, Kasai H, Ishiguro H, Kawabata H, Morita S, Haga H, Kataoka TR, Uozumi R, Ohno S, Toi M. Masuda N, et al. Among authors: bando h. Breast Cancer Res Treat. 2021 Jul;188(1):117-131. doi: 10.1007/s10549-021-06184-w. Epub 2021 Mar 25. Breast Cancer Res Treat. 2021. PMID: 33763789 Free PMC article. Clinical Trial.

2

Expression of uridine and thymidine phosphorylase genes in human breast carcinoma.

Kanzaki A, Takebayashi Y, Bando H, Eliason JF, Watanabe Si S, Miyashita H, Fukumoto M, Toi M, Uchida T. Kanzaki A, et al. Among authors: bando h. Int J Cancer. 2002 Feb 10;97(5):631-5. doi: 10.1002/ijc.10105. Int J Cancer. 2002. PMID: 11807789

3

[Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer].

Kuroi K, Tanaka C, Bando H, Saji S, Hayashi K, Toi M. Kuroi K, et al. Among authors: bando h. Gan To Kagaku Ryoho. 2002 Jan;29(1):55-60. Gan To Kagaku Ryoho. 2002. PMID: 11816478 Japanese.

4

Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer.

Toi M, Bando H, Ogawa T, Muta M, Hornig C, Weich HA. Toi M, et al. Among authors: bando h. Int J Cancer. 2002 Mar 1;98(1):14-8. doi: 10.1002/ijc.10121. Int J Cancer. 2002. PMID: 11857378

5

Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread.

Bando H, Matsumoto G, Bando M, Muta M, Ogawa T, Funata N, Nishihira J, Koike M, Toi M. Bando H, et al. Among authors: bando m. Jpn J Cancer Res. 2002 Apr;93(4):389-96. doi: 10.1111/j.1349-7006.2002.tb01269.x. Jpn J Cancer Res. 2002. PMID: 11985788 Free PMC article.

6

[Current indications for mastectomy in patients with breast cancer].

Nakanishi C, Toi M, Saji S, Bando H. Nakanishi C, et al. Among authors: bando h. Nihon Geka Gakkai Zasshi. 2002 Nov;103(11):821-4. Nihon Geka Gakkai Zasshi. 2002. PMID: 12478859 Japanese.

7

Weekly schedule of docetaxel in breast cancer: evaluation of response and toxicity.

Kuroi K, Bando H, Saji S, Toi M. Kuroi K, et al. Among authors: bando h. Breast Cancer. 2003;10(1):10-4. doi: 10.1007/BF02967619. Breast Cancer. 2003. PMID: 12525757 Review.

8

Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: implication for method to detect expression of these molecules in clinic.

Ogura O, Kanzaki A, Bando H, Ogura T, Toi M, Takebayashi Y. Ogura O, et al. Among authors: bando h. Cancer Lett. 2003 Feb 10;190(1):97-104. doi: 10.1016/s0304-3835(02)00098-8. Cancer Lett. 2003. PMID: 12536082

9

Decision tree and paradigms of primary breast cancer: changes elicited by preoperative therapy.

Toi M, Bando H, Saji S. Toi M, et al. Among authors: bando h. Med Sci Monit. 2003 May;9(5):RA90-5. Med Sci Monit. 2003. PMID: 12761467 Review.

10

Protracted administration of weekly docetaxel in metastatic breast cancer.

Kuroi K, Bando H, Saji S, Toi M. Kuroi K, et al. Among authors: bando h. Oncol Rep. 2003 Sep-Oct;10(5):1479-84. Oncol Rep. 2003. PMID: 12883727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

727 results

Search Page

Filters